Search Within

Heather Jolie Landau

Formats
  1. Meeting Abstract (281)
  2. Journal Article (124)
  3. Research Letter (15)
  4. Book Section (5)
  5. Review (3)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Guidelines (1)
Groups
  1. Bone Marrow Transplant (432)
  2. Center for Hematologic Malignancies (432)
  3. Department of Medicine (432)
  4. Hematologic Malignancies, Division of (432)
  5. Survivorship Research (432)
  6. Myeloma (246)

More Groups

People
  1. Sergio Giralt (260)
  2. Hani Hassoun (221)
  3. David Chung (206)
  4. Alexander Lesokhin (184)
  5. Gunjan Shah (161)
  6. Sham Mailankody (144)

More People

Years
  1. 2025 (10)
  2. 2024 (51)
  3. 2023 (48)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Blood (153)
  2. Clinical Lymphoma, Myeloma and Leukemia (53)
  3. Biology of Blood and Marrow Transplantation (48)
  4. Journal of Clinical Oncology (24)
  5. Bone Marrow Transplantation (12)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (164)
  2. Elsevier Inc. (110)
  3. Nature Publishing Group (29)
  4. American Society of Clinical Oncology (25)
  5. Taylor & Francis Group (21)
  6. Ferrata Storti Foundation (8)

More Publishers

Results (432)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients with light chain amyloidosis treated with NEOD001 achieve rapid organ responses that are independent of previous plasma cell-directed therapies
    Meeting Abstract

    Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction independently of previous haematological response
    Meeting Abstract

    Liedtke, M. M.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    European Journal of Heart Failure (2017)

    Fulltext@MSK | Save
  • Re-immunization following autologous hematopoietic stem cell transplantation (Auto HCT) is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Meeting Abstract

    Shah, G.; Palazzo, M.; Copelan, O.; Seier, K.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Organ biomarker responses in patients with light chain amyloidosis treated with NEOD001 are independent of previous hematologic response
    Meeting Abstract

    Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G.; Assal, A.; Hsu, M.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; Smith, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Post autologous transplant (autoHCT)therapies in high risk MM. Subgroup analysis of Phase III BMTCTN 0702 STAMINA: autoHCT followed by lenalidomide maintenance(Len)(AM) vs auto HCT and Len and bortezomib (BZ) and dexamethasone consolidation Len maintenance(ACM) vs tandem autoHCT Len maintenance
    Meeting Abstract

    Krishnan, A.; Pasquini, M.; Blackwell, B.; Knust, K.; Bashey, A.; Devine, S.; Efebera, Y.; Ganguly, S.; Gasparetto, C.; Geller, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction: Results from a phase 1/2 study
    Meeting Abstract

    Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Proteomic profiling in plasma cell disorders: A feasibility study
    Journal Article

    Mailankody, S.; Devlin, S. M.; Korde, N.; Lendvai, N.; Lesokhin, A.; Landau, H.; Hassoun, H.; Ballagi, A.; Ekman, D.; Chung, D. J.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
    Journal Article

    Shah, G. L.; Landau, H.; Londono, D.; Devlin, S. M.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: Efficacy and analysis of risk factors associated with poor stem cell collection efficiency*
    Journal Article

    Ogunniyi, A.; Rodriguez, M.; Devlin, S.; Adel, N.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Koehne, G.; Mailankody, S.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save